Medicine and Dentistry

1. Patient 100%
2. Esophageal Cancer 94%
3. Positron Emission Tomography-Computed Tomography 92%
4. Neoadjuvant Chemotherapy 64%
5. Neoplasm 61%
6. Association 59%
7. Fluorodeoxyglucose F 18 59%
8. Therapeutic Procedure 58%
9. Lymph Node 38%
10. Neoadjuvant Therapy 35%
11. Malignant Neoplasm 35%
12. Chemotherapy 34%
13. Fat 29%
14. Incidence 29%
15. Sarcopenia 29%
16. Esophageal Adenocarcinoma 29%
17. Older People 29%
18. Glucose 29%
19. Geriatric Assessment 29%
20. Fluorouracil 29%
21. PET-MRI 29%
22. Experience 29%
23. Irinotecan 29%
24. Treatment Response 29%
25. Dynamic Contrast-Enhanced MRI 29%
26. Colorectal Carcinoma 29%
27. Age 17%
28. Toxicity 14%
29. Analysis 14%
30. Overall Survival 14%
31. Endobronchial Ultrasonography 12%
32. Hazard Ratio 11%
33. Tumor Regression 11%
34. Vascular Tissue Neoplasm 11%
35. Oncology 11%
36. Primary Tumor 10%
37. Metastatic Carcinoma 10%
38. Epidermal Growth Factor Receptor 9%
39. Adenocarcinoma 8%
40. Prognosis 8%
41. Diagnosis 8%
42. Fine-Needle Aspiration 8%
43. Surgical Margin 8%
44. Male 8%
45. Informed Consent 8%
46. Geriatrician 7%
47. Drug Dose Reduction 6%
48. Hospital 6%
49. Cancer Staging 6%
50. Rank Sum Test 5%